GlaxoSmithKline reported a sharp fall in fourth-quarter earnings as the British drug maker faced challenging market conditions, particularly in the U.S.
from WSJ.com: US Business http://ift.tt/1EFRzQe
via IFTTT
from WSJ.com: US Business http://ift.tt/1EFRzQe
via IFTTT
No comments:
Post a Comment